Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011849 (
diabetes
)
277,896
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Diabetic ketoacidosis is an acute medical emergency that requires immediate diagnosis and treatment. Diagnosis may be established rapidly by measurement of urinary glucose and ketones, arterial blood pH and blood gases, and serum ketones. Rapid infusion of large volumes of fluids and electrolytes, together with continuous infusion of low doses of insulin, provides effective restoration of fluid and electrolyte balance and correction of metabolic derangements.
Hyperosmolar nonketotic coma
is characterized by marked hyperglycemia in the absence of ketoacidosis and occurs usually in patients with mild adult-onset
diabetes
. Symptoms develop more slowly than in diabetic ketoacidosis. Treatment is the same for both conditions. In alcoholic ketoacidosis, hyperketonemia is present without hyperglycemia. The syndrome differs from diabetic ketoacidosis in that blood glucose levels are lower and glycosuria is absent. Treatment consists of intravenous administration of dextrose in water and, if necessary, of sodium bicarbonate. Insulin administration usually is not necessary.
...
PMID:Combating diabetic ketoacidosis and other hyperglycemic-ketoacidotic syndromes. 0 17
Hyperosmolar nonketotic coma
is characterized by hyperglycemia, hyperosmolarity and dehydration in the absence of ketoacidosis. Two cases of hyperosmolar nonketotic coma, in which both the patients recovered, were presented. One of the cases was a 59-year-old female who had suffered from a metastatic brain tumor. After removal of the tumor, the patient's condition improved for a period. This was followed by a period of frequent vomiting, subsequently followed by coma. The laboratory data showed the absence of ketoacidosis in the blood sugar measured at 672 mg/dl and serum osmolarity at 343.1 mOsm./kg. The other case was a 74-year-old female who was admitted to the clinic because of cerebral thrombosis. Her caloric in-take was restricted and insulin was administered because of a mild
diabetes mellitus
which occured after admission. Then she entered a hyperosmolar non-ketotic coma. The laboratory data revealed blood sugar to be 1068 mg/dl and serum osmolarity to be 418 mOsm./kg. Immediately after large amounts of intravenous drip infusion and insulin were administerd, she recovered from the syndrome. The clinical observations and the pathogenesis of this syndrome were discussed.
...
PMID:[Two cases of nonketotic hyperosmolar coma in neurosurgery (author's transl)]. 91 16
DKA and
HHNK
are emergency conditions requiring quick medical care and nursing intervention. DKA can develop at any age and is most likely to occur in the insulin-dependent patient. The hallmark signs of DKA are a relative or absolute lack of insulin along with acidosis, ketosis, and hyperglycemia. Insulin and fluid and electrolyte therapy are initiated to control the hyperglycemia and prevent shock and further complications. The patient in
HHNK
presents with a very high serum glucose level (higher than in DKA), a high serum osmolarity, and usually no ketosis or acidosis. The patient may also experience more severe and sudden neurologic changes than those in DKA. Most patients who experience
HHNK
are older and may also have some other underlying disease process present. The nursing process should be used to correct the fluid and electrolyte imbalances and to prevent further complications in both DKA and
HHNK
. The patient needs to understand the reasons for his or her hyperglycemic crisis and how to prevent it from occurring in the future. Assessment of the patient's knowledge about
diabetes
is essential so that proper education can be incorporated into his or her plan of care.
...
PMID:Fluid and electrolyte disorders associated with diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic coma. 312 Jan 55
Hyperosmolar nonketotic diabetic coma (
HHNC
) is a syndrome of acute decompensation of
diabetes mellitus
, occurring mainly in the elderly and characterized by marked hyperglycemia, hyperosmolarity, severe dehydration, occasional neurological signs, obtunded sensorium, and absence of ketonemia or acidosis. The mortality is high. Early aggressive therapy with large amounts of normal or half normal saline, insulin, and potassium is of prime importance. Since associated diseases cause most fatalities the importance of managing these problems effectively cannot be overemphasized. Complications of therapy can be congestive heart failure secondary to excessive fluid administration, hypoglycemia if too much insulin is given, and hypokalemia if potassium is inadequately replaced.
...
PMID:Hyperosmolar nonketotic diabetic coma: diagnosis and management. 331 90
Diabetes mellitus
affects almost 5.5 million Americans each year. An estimated additional 5 million individuals may have
diabetes
, but remain undetected. Individuals with
diabetes
are at high risk for the development of micro- and macrovascular disease, diabetic coma and adverse outcome of pregnancy. The rate at which these complications develop are now partially identifiable for the United States. For 5 potentially preventable complications (retinopathy, adverse outcome of pregnancy, vascular disease, nephropathy and diabetic coma) the morbidity and mortality rates can now be calculated. There exist 50,000 cases of blindness due to
diabetes
with an additional 5800 new cases each year. Adverse outcome of diabetic pregnancy occurs in over 18,000 births each year, with as many as 4500 related perinatal deaths. Each year 40,000 diabetics are required to have a lower extremity amputation. Of the already 70,000 diabetics who have had an amputation, 25,000 will die this year. End stage renal disease affects 4000 diabetics each year. During the same time period, of the 7500 existing cases of end stage renal disease, 2000 will result in mortality cases. Diabetic coma (DKA and
HHNK
) accounts for 67,400 hospitalizations and results in 3600 deaths each year. Together these complications and those associated with cardiovascular disease account for 323,000 deaths with
diabetes
as the underlying or contributing cause in the United States.
Diabetes
Res Clin Pract 1985 Oct
PMID:An epidemiological model for diabetes mellitus in the United States: five major complications. 393 16
Diabetic hyperosmolar coma
is a syndrome of marked hyperglycemia and minimal ketoacidosis. In general, the serum glucose concentrations are not predictive of the serum ketoacid concentrations in acutely decompensated
diabetes
. The endocrine factors that modulate glucose concentrations may be different from those that modulate ketoacid concentrations in patients with acutely decompensated
diabetes
. To test this hypothesis, regression analysis was used to determine the endocrine and metabolic characteristics that correlated with serum concentrations of glucose and ketoacids in 26 diabetic patients with spontaneous, acute hyperglycemia. All patients had a serum glucose level greater than 390 mg/dl, and ketoacid levels were from 0.17 to 25.5 mM. Multiple regression analysis showed that increased serum glucose concentrations correlated with increased plasma glucagon levels (p = 0.0007, r2 = 0.45), but with no other factors. Increased total ketoacid levels (acetoacetate plus 3-hydroxybutyrate) correlated with increased free fatty acid levels (p = 0.0001), decreased C-peptide levels (p = 0.002), and increased body mass index (p = 0.002) (r2 = 0.72). Body mass index only correlated with ketoacid levels, when it was analyzed with C-peptide and free fatty acid levels. A model is proposed that predicts the serum glucose and ketoacid concentrations in patients with acutely decompensated
diabetes
. Glucagon modulates the serum glucose concentration in these patients with an absolute or relative insulin deficiency. Total serum ketoacid levels are determined by the serum free fatty acid concentration, residual pancreatic insulin secretion (as reflected by C-peptide), and the patient's body habitus. This model allows for the marked hyperglycemia and minimal ketosis of diabetic nonketotic hyperosmolar coma, as well as the glucose and ketoacid concentrations in other presentations of acutely decompensated
diabetes
.
...
PMID:Determinants of glucose and ketoacid concentrations in acutely hyperglycemic diabetic patients. 643 13
Hyperosmolar coma
was the presenting feature of type I
diabetes
in a 20 year old man. Ischemic ECG abnormalities (downsloping ST depression of 5 mm in the anterior leads) were present during the comatose state but not in the following days, when a satisfactory metabolic control was achieved. Coronary heart disease was excluded on the basis of the normal response to a treadmill test carried out 6 months later. Hyperglycemia, hypokalemia, shock, hyperventilation and perhaps hyperosmolarity are responsible for these ECG changes. Caution must be used before considering such ECG patterns as ischemic in patients with this type of coma.
...
PMID:[Transitory ECG changes of an ischemic type during hyperosmolar non-ketoacidotic coma]. 718 21
Diabetes mellitus
is prevalent among the elderly. Although the principles of management of
diabetes
are fundamentally the same in both the young and elderly, many aspects of the disease and its manifestations are unique to the elderly. Older patients may have atypical presentations of
diabetes
. Numerous factors may impair adequate nutrition and dietary and exercise compliance in the elderly. Pharmacologic therapy, with either sulfonylureas or insulin, entails a particular risk for hypoglycemia among the elderly, who are more susceptible to hypoglycemia and are more likely to have neuroglycopenic symptoms.
Diabetic hyperosmolar coma
occurs predominantly in the older type II diabetic population. It requires aggressive hydration and insulin therapy, but most patients can ultimately be managed without insulin. The macrovascular complications (coronary and peripheral vascular disease) are the major source of morbidity and mortality among elderly diabetics, but microvascular complications (nephropathy, retinopathy, neuropathy) also occur and often respond to a variety of therapeutic interventions.
...
PMID:Diabetes mellitus in the elderly. 765 91
Rhabdomyolysis (RM) is a clinical and laboratory syndrome resulting from leakage of muscle cell contents into plasma. The increased plasma concentration of the substances released such as creatine kinase (CK) permits the clinician to diagnose this syndrome. Non-traumatic RM has occasionally been reported in patients with diabetic decompensation. We encountered about 44 cases of RM in 265 diabetic emergencies (including DKA or hyperosmolar, or both) during the period from 1984-1 to 1990-6, diagnosed based on (1) serum creatine kinase (CK) > 1000 IU/l and (2) the absence of acute myocardial infarction, stroke and end-stage renal disease. On admission, those who presented with RM had significantly higher concentration of blood urine nitrogen (BUN) (83.3 +/- 5.9 vs. 58.8 +/- 2.4 mg/dl, P < 0.05), creatine (4.45 +/- 0.4 vs. 2.97 +/- 0.1 mg/dl, P < 0.05) and serum osmolarity (386.5 +/- 5.2 vs. 351.6 +/- 2.4 mOsm/kg, P < 0.05). The mortality within 1 week of diabetic emergencies (38.5% for DKA, 35.5% for
HHNK
) was higher in patients with RM than those without RM (9.7% for DKA, 26.7% for
HHNK
). There was a correlation (r = 0.49, P < 0.05) between the levels of serum creatinine and CK in patients with RM.(ABSTRACT TRUNCATED AT 250 WORDS)
Diabetes
Res Clin Pract 1994 Dec 31
PMID:Rhabdomyolysis in diabetic emergencies. 773 1
Hyperosmolar coma
which is characterized by severe hyperglycemia in absence of chetosis is very rare in pediatric age with only 11 cases reported in the literature. The outcome of the condition is usually poor with mental retardation being the most common event. Here a case of hyperosmolar coma is described in a female of three months of age who was treated with peritoneal dialysis 11 hours after admittance to hospital. This female patient has been receiving insulin from three months of age and today at the age of 10 years she leads a normal life despite being on insulin therapy. A very low level of C-peptide (<0.3 ng/ml) clearly confirms she is affected by Type 1
diabetes
. To our knowledge this is the first case report of hyperosmolar coma in a neonate with Type 1
diabetes
who survived this condition without late neurological consequences.
...
PMID:Peritoneal dialysis in an infant with type 1 diabetes and hyperosmolar coma. 1126 66
1